Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q562E7
UPID:
WDR81_HUMAN
Alternative names:
-
Alternative UPACC:
Q562E7; B3KW16; B3KXU1; B7Z579; E9PHG7; Q24JP6; Q8N277; Q8N3F3; Q8TEL1
Background:
WD repeat-containing protein 81 plays a crucial role in cellular processes by acting as a negative regulator of PI3 kinase/PI3K activity associated with endosomal membranes. It influences endosome fusion, recycling, sorting, and transport, essential for cellular homeostasis and signaling. Its involvement in aggrephagy and mitochondrial organization underscores its multifunctional nature.
Therapeutic significance:
Given its pivotal role in neurodevelopmental disorders such as Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 2, and congenital Hydrocephalus, WD repeat-containing protein 81 emerges as a promising target for therapeutic intervention. Understanding its mechanisms could pave the way for novel treatments for these debilitating conditions.